SELENA JUAREZ STUART M.D. NPI 1629236575

NPI Details

Selena Juarez Stuart, M.D. is a hematology and oncology internal medicine in New Braunfels, TX with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Selena Juarez Stuart, M.D. NPI is 1629236575. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:2008

The provider's business location address is:

1448 E COMMON ST
NEW BRAUNFELS, TX
ZIP 78130-162
Phone: (830) 643-1762
Fax: (830) 609-7702

The NPI 1629236575 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Ferritin (blood protein) level (HCPCS:82728)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ct scan of chest with contrast (HCPCS:71260)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Protein measurement, serum (HCPCS:84165)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Unclassified drugs (HCPCS:J3490)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ct scan of chest without contrast (HCPCS:71250)
• Drawing of blood for a medical problem (HCPCS:99195)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Blood test, clotting time (HCPCS:85610)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Declotting of central venous tube (HCPCS:36593)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 5/28/2008 and was last updated on 12/2/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.